Benralizumab does not impair antibody response to seasonal influenza vaccination in adolescent and young adult patients with moderate to severe asthma: results from the Phase IIIb ALIZE trial - Concepedia

Concepedia

Publication | Open Access

Benralizumab does not impair antibody response to seasonal influenza vaccination in adolescent and young adult patients with moderate to severe asthma: results from the Phase IIIb ALIZE trial

DOI Full Paper Access

45

Citations

9

References

2018

Year

Pamela L. Zeitlin, Mila A. Leong, Jeremy Cole, Raburn M. Mallory, Vivian H. Shih, Richard F. Olsson, Mitchell Goldman

Journal of Asthma and Allergy

Abstract

Benralizumab did not impair the antibody response to seasonal virus vaccination in adolescents and young adult patients with moderate to severe asthma.

References

	Year	Citations

Page 1